Graeme O'Neill reports back from the recent CSIRO Horizons in Livestock Science conference at the Gold Coast, which addressed the progress, challenges and problems associated with redesigning livestock.

Zoonoses are a growing global problem requiring a global surveillance and control system, reports Graeme O'Neill.

Is the tendency to misfold and form aggregates of fibrils and gels the true nature of proteins? Graeme O'Neill reports.

Ruth Beran finds that few people want to stick their necks out when it comes to touting the benefits of stem cell research.

Profiling proteins is a challenging undertaking. But new research is providing new insights into protein structure and function, reports Susan Williamson.

The latest medical technology is all very well - if you can afford it. Susan Williamson looks at how one Australian group is coming up with practical healthcare solutions for the developing world.

Should Australia lift its ban on therapeutic cloning? Few topics in Australian science have generated such strong opinions. Ruth Beran reports.

The Australian Stock Exchange has created a market that attracts not only local biotechnology companies, but also gives opportunities to foreign companies that would be unable to attract capital in their own markets. Helen Schuller reports.

Ruth Beran wraps up a recent report that gives Australia a high rating against other major centres of pharma R&D.

Australia, take a bow -- you've proved you can compete in the global clinical trials market. But let's not get too complacent, writes Graeme Blackman.